UCL-led researchers launch a world-first project targeting low eye pressure, offering new hope for patients at risk of vision loss and glaucoma-related damage.
To improve understanding of the impact and epidemiology of Alzheimer’s disease, Project Alzheimer’s Value Europe (PAVE) demonstrates the prevalence of Alzheimer’s across the stages of the disease, including prodromal and preclinical – which aren’t recognised by previous studies.
Daryl Newsome FBDO R CL SMC(Tech), President of the Association of British Dispensing Opticians, examines the important role that optical practices can play in dealing with eye problems.
Misdiagnoses and delays are far too common for people with lung conditions. Rachel Warren, Senior Policy Officer at Asthma + Lung UK and Policy Lead (Diagnosis) at the Taskforce for Lung Health, explores how new community diagnostic centres could help tackle this issue.
The most recent omicron subvariants have caused new infection spikes across the United States, as researchers find they are better at eluding vaccines.
Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.
Tara M. DeSilva from the Department of Neurosciences, Cleveland Clinic, walks us through regenerative therapies for multiple sclerosis, including comment on clues from studying normal brain development.
